ACHV Stock Price
Achieve Life Sciences, Inc.
ACHV stock price is $7.00 (+0.00% on the day), giving Achieve Life Sciences, Inc. a market cap of $720.32M. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.
ACHV Stock Overview
- Price
- $7.00
- Previous close
- $7.00
- Open
- $6.98
- Market cap
- $720.32M
- P/E ratio
- -13.2
- 52-week range
- $2.62 - $8.64
- 1-year price target
- $14.36
- Sector
- Healthcare
- Industry
- Biotechnology
- Exchange
- NSC
- MarketXLS Rank
- 27
About Achieve Life Sciences, Inc.
Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes cytisinicline for smoking cessation and nicotine addiction. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license and supply agreement with Sopharma AD and University of Bristol Achieve Life Sciences, Inc., which is headquartered in Vancouver, Canada.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ACHV | $7.00 | 0% | 1.64M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Achieve Life Sciences, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW